Bicara Therapeutics · 1 day ago
Vice President, Head of US Medical Affairs
Boston
Full-time
Hybrid
Director/Executive
$330K/yr - $415K/yr
15+ years expBicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. They are seeking an experienced and strategic Vice President, Head of US Medical Affairs to lead and shape the company's US medical affairs function, focusing on the successful launch preparation and commercialization of their lead asset, ficerafusp alfa.
BiopharmaBiotechnologyLife ScienceOncologyTherapeutics
Responsibilities
In alignment with global objectives, develop and execute the US medical affairs strategy aligned with the company’s global Medical Affairs and overall business and commercialization objectives, with a focus on preparing the external landscape for product launch
Provide scientific and clinical expertise to internal teams, external partners, healthcare professionals, and key stakeholders to inform strategies and educational initiatives that support the successful US launch of ficerafusp alfa
Lead, build, and manage a high-performing Medical Affairs team within the US region
Foster relationships with key opinion leaders (KOLs), healthcare providers, regulatory authorities, and patient advocacy groups to build trust, credibility, and awareness around the upcoming product
Collaborate with Global Medical Affairs, R&D, Commercial, Regulatory, and other functions to ensure scientific accuracy, compliance, and alignment in all medical activities that influence product positioning
Oversee the planning and execution of scientific communications, educational programs, and medical information initiatives designed to shape the external scientific and clinical landscape in the US region
Provide strategic direction and oversight for US Investigator-Initiated Trials (IITs), ensuring alignment with corporate and global medical strategies. Partner with the global IIT working group to shape research priorities and strengthen the integration of US initiatives within the global evidence-generation framework
Provide medical insights to inform evidence generation activities, including observational studies, registries, and real-world data initiatives, to demonstrate value and support market acceptance
Ensure all medical activities are conducted in compliance with applicable regulations, industry standards, and ethical guidelines
Represent the company at scientific conferences, advisory boards, and industry forums, actively positioning Bicara as a credible scientific partner ahead of product launch
Stay abreast of advances in the external medical landscape, competitive developments, and clinical trial outcomes to strategically position Bicara’s interests
Qualification
Required
Advanced degree required: MD (strongly preferred), PhD, or PharmD
Minimum 15 years of medical affairs experience in biopharma, including leadership of launch-stage assets
Familiarity with oncology is advantageous
History of building trusted KOL networks and influencing scientific communities across multiple regions
Strong track record of evidence generation, publication leadership, and external communications
Comfortable operating in a growth-stage biotech environment with dynamic priorities
Willingness to travel internationally (up to 30%) and work flexibly in a hybrid setting
Preferred
Clinical or research expertise in oncology or rare diseases
Company
Bicara Therapeutics
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact. It is a sub-organization of Biocon.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$313MKey Investors
Biocon
2024-09-13IPO
2023-12-12Series C· $165M
2023-03-06Series B· $108M
Leadership Team
Claire Mazumdar
Chief Executive Officer
David Raben
CMO, Bicara Therapeutics
Recent News
2026-01-13
2026-01-12
Company data provided by crunchbase